Management of common adverse effects of antipsychotic medications

Cited by (572)

Items 301–400 of 572

1. Psychotropic drugs and risk of pancreatitis: a systematic review and meta-analysis
   Xiao-Qian Peng, Jun Huang, Henry H. Y. Tong, Wen‐Wang Rao · 2025 · Psychiatry Research
2. Diagnostic Conversion From Psychotic Unipolar Depression to Bipolar and Psychotic Disorders: A Swedish Registry‐Based Study
   Ahmed Al‐Wandi, Mikael Landén, Axel Nordenskjöld · 2025 · Acta Psychiatrica Scandinavica
3. Efficacy of non-invasive brain stimulation in treatment-resistant schizophrenia: A systematic review and network meta-analysis
   Harry Kam Hung Tsui, Vincent Law, Charmaine Tsz Wing Wong, Wing Tse, Hiu Ching LIM, Ciren ZHUOMA, Kelvin O. Lim, Georg S. Kranz, Sherry Kit Wa Chan · 2026 · Neuroscience & Biobehavioral Reviews
4. A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction
   Peter J. Weiden, Cory D. Saucier, April Mitchell Foster, Amy Claxton, Soumya Chatuvedi, Colin L. Sauder, Kaitlin LaGasse, Sloan Rucker, Kristi Jackson, Stephen R. Marder et al. · 2026 · Schizophrenia Bulletin Open
5. Linking the relationship between drug-induced osteoporosis and the gut microbiota
   Monika Martiniaková, Anna Šarocká, Noémi Pénzes, Vladimíra Mondočková, Aneta Ševčíková, Soňa Čierniková, Veronika Kováčová, Roman Bíro, Joanna Folwarczna, Radoslav Omelka · 2026 · Frontiers in Endocrinology
6. Acupoints with potential to treat schizophrenia: A systematic review and data mining analysis
   Xiaotong Wang, Haixiong Lin, Kangju Li, Tao Huang, Xiumin Jiang, Shengwei Wu, Aixiang Xiao, Lin Yu, Yongjun Chen · 2020 · European Journal of Integrative Medicine
7. Physical health assessment for people with a severe mental illness
   Aby Mitchell, Barry Hill · 2020 · British Journal of Nursing
8. Death by fecaloma
   Yosuke Usumoto, Michael S. Pollanen · 2021 · Forensic Science Medicine and Pathology
9. POTENTIALLY INAPPROPRIATE MEDICATIONS AND DRUG-DRUG INTERACTIONS IN ELDERLY PATIENTS WITH MENTAL ILLNESS
   Oleg O. Kirilochev, V.S. Tarkhanov · 2021 · Современные проблемы науки и образования
10. Efficacy and Safety of Baclofen for Treatment of Alcohol Dependence: An Updated Meta-Analysis and Meta-Regression Study
    Wiraphol Phimarn, P. Chamnanjit, W. Anunworapunya, K. Saramunee, Bunleu Sungthong · 2022 · Indian Journal of Pharmaceutical Sciences
11. Recruitment to a trial of antipsychotic reduction: impact of an acceptability study
    Georgina Buswell, Zoë Haime, Nadia E. Crellin, Jacki L. Stansfeld, Stefan Priebe, Maria Long, Joanna Moncrieff · 2023 · BMC Medical Research Methodology
12. Effect of Shi-Zhen-An-Shen herbal formula granule in the treatment of young people at ultra-high risk for psychosis: a pilot study
    Hong Zhu, Yanzhe Ning, Sisi Zheng, Sitong Feng, Linrui Dong, Hongxiao Jia · 2023 · Frontiers in Psychiatry
13. Comparison of inpatient psychiatric medication management in gender diverse youth with cisgender peers
    Nina Carrillo, Maren A McGurran, Brittany L. Melton, Karen E. Moeller · 2023 · Mental Health Clinician
14. A descriptive analysis of spontaneous reports of antipsychotic‐induced tardive dyskinesia and other extrapyramidal symptoms in the Japanese Adverse Drug Event Report database
    Yosuke Saga, Chih‐Lin Chiang, Akihide Wakamatsu · 2023 · Neuropsychopharmacology Reports
15. The Association of Antipsychotic Postponement With 5-Year Outcomes of Adolescent First-Episode Psychosis
    Tomi Bergström, Tapio Gauffin · 2023 · Schizophrenia Bulletin Open
16. Late onset psychosis treatment with adjunctive medicines
    И. С. Бокша, Olga Konstantinovna Savushkina, V. Sheshenin, Е. Б. Терешкина, T. A. Prokhorova, Почуева Валерия Витальевна, Gulnur Burbaeva · 2023 · Frontiers in Psychiatry
17. Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patients
    Hanna Puolakka, Anssi Solismaa, Leo‐Pekka Lyytikäinen, Merja Viikki, Niko Seppälä, Nina Mononen, Terho J. Lehtimäki, Olli Kampman · 2024 · Acta Neuropsychiatrica
18. Mutual effects of gestational diabetes and schizophrenia: how can one promote the other?: A review
    Kholoud Alawi Ghamri · 2024 · Medicine
19. Aberrant Hippocampal Neuroregenerative Plasticity in Schizophrenia: Reactive Neuroblastosis as a Possible Pathocellular Mechanism of Hallucination
    Mercy Priyadharshini Babu Deva Irakkam, Jerly Helan Mary Joseph, Mahesh Kandasamy · 2024 · Neurosignals
20. Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel
    Miquel Bernardo, Marina Díaz‐Marsá, Ana María González-Pinto, Manuel Martín Carrasco, Víctor Pérez, Pilar Alejandra Sáiz, Eduard Vieta, Marta Torrens, Celso Arango, Benedicto Crespo‐Facorro · 2025 · Neurology and Therapy
21. Schizophrenia Management Approaches: A Look at Progress and Challenges
    Kesha Pareshkumar Patel, Terry L Oroszi · 2025 · World Journal of Neuroscience
22. Role of Glial Cells and Receptors in Schizophrenia Pathogenesis
    Yousef Tizabi, Marta Cristina Antonelli, Daniela Tizabi, Michael Aschner · 2025 · Neurochemical Research
23. The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation
    Uros Velickovic, Dragica Selaković, Nemanja U. Jovicic, Marina M. Mitrović, Vladimir S. Janjic, Sara Rosic, Suzana Randjelovic, Dragan Milovanovic, Gvozden Luka Rosic · 2025 · Biomedicines
24. Novel nanostructured lipid carriers with lurasidone hydrochloride for intranasal administration for improved bioavailability
    Tanvi Kadam, Surendra Satyanarayan Agrawal, Saritha Rakesh Shetty · 2025 · Therapeutic Delivery
25. Antipsychotic Discontinuation and Re-initiation in Pregnant Women With Schizophrenia: A Retrospective Cohort Study From South Korea
    Jiyeon Kim, Julia Kaminska, Ye-Jee Kim, Sung Woo Joo, Bo Ram Yang · 2025 · Schizophrenia Bulletin
26. Synthesis of 2-(3-aminopropyl)benzopyrans as potential antipsychotic agents targeting D2/D3 and 5-HT2A receptors
    Álvaro Bernabeu-Sanchis, María José Varela, Ainhoa García, Carlos Villarroel-Vicente, Laura Vila, Marı́a Isabel Loza, Jose Manuel Brea, Diego Cortés, Nuria Cabedo · 2025 · Bioorganic & Medicinal Chemistry
27. Safety Outcomes with the Long-Acting Subcutaneous Antipsychotic TV-46000 in Schizophrenia: A Post Hoc Analysis of Behavioral, Neuromotor, Endocrine, and Cardiometabolic Outcomes from Two Phase 3 Studies
    Christoph Ulrich Correll, Helena Knebel, Eran Harary, Roy Eshet, Orna Tohami, Mark Suett, Nir Adam Sharon, Kelli R. Franzenburg, John M. Kane · 2025 · CNS Drugs
28. Haloperidol Induced Orofacial Dyskinesia: Clinical Insights Into Buccolingual Masticatory Syndrome
    Gudisa Bereda · 2025 · Clinical Case Reports
29. The State of the Art: Pharmacogenomics, Multi-Omics, and Translational Barriers in Antipsychotic Therapy
    Neha Tandon, Milica Branković, Aleksandar Popovic, Dubravka Švob Štrac, Janko Samardžić · 2025 · Pharmaceutical science.
30. Neuroleptic Agent Toxicity
    Marina N. Boushra, Shivaraj Nagalli · 2021 · StatPearls
31. Management of delirium at an academic medical center: Plans for antipsychotic prescribing upon discharge
    Lauren Halavonich, Sophie Robert, Dan McGraw, Erin R. Weeda, Kristen Mullinax, Bailey Bass · 2020 · Mental Health Clinician
32. Practice of prescribing antipsychotics in schizophrenia during 2013-2018 based on data from the National Health Fund
    Marta Anczewska, Marek Balicki, Amelia Droździkowska, Piotr Wacław Gorczyca, Jolanta Janus, Sylwia Paciorek, Robert Plisko, Mariusz Zięba · 2021 · Psychiatria Polska
33. Oral Ulcers as an Unpredictable Adverse Reaction to Quetiapine Use in a Patient With Schizophrenia
    Maytinee Srifuengfung, Thanisorn Sukakul, Chalermsri Pummangura, Somporn Srifuengfung, Natee Viravan · 2021 · Journal of Clinical Psychopharmacology
34. The Biopsychosocial Model Advanced by Evolutionary Theory
    Adam Hunt, Paul St John‐Smith, Riadh Abed · 2021 · Cambridge University Press eBooks
35. First-generation antipsychotics use and reduced risk of pneumonia—Clinical implications in SARS-CoV2 treatment: A systematic review and meta-analysis of observational studies
    Abhirami Eby, Elsa Jacob, P. Samuel Gideon George · 2022 · Journal of Applied Pharmaceutical Science
36. Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review
    Neasa Kelly, Andrew Kilmartin, K. Lannon, Caren Lee, Rory McLoughlin, Lara Mulvanny, Omnyiah Mohamed, Mairead Treacy, Karen Rossi, Juliette O’Connell · 2022 · European Journal of Clinical Pharmacology
37. Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
    Spyridon Siafis, Johannes Schneider‐Thoma, Tasnim Hamza, Irene Bighelli, Shimeng Dong, Wulf‐Peter Hansen, John M. Davis, Georgia Salanti, Stefan Leucht · 2023 · BMJ Open
38. Association Between Abnormal Metabolic Parameters and Receiving Subsequent Interventions in Children and Adolescents Initiating Second-Generation Antipsychotics
    Swarnava Sanyal, Ning Lyu, Chadi Albert Calarge, Paul J. Rowan, Rajender R. Aparasu, Susan Abughosh, Hua Chen · 2023 · Journal of Child and Adolescent Psychopharmacology
39. Schizophrenia and Other Late-Life Psychoses
    Francesco Saverio Bersani, Elisabeth Prevete, Roberto Vicinanza · 2024 · Springer eBooks
40. Auricular Acupressure Improve Constipation of Patients With Schizophrenia: A Pilot Randomized Controlled Study
    Ciao-Min Gong, Hui‐Chuan Huang, Ju-Han Liu, Shiou‐Shiun Yu, Yu‐Ting Chen · 2024 · Biological Research For Nursing
41. The Positive Impact of Memorizing the Qur'an on the Cognitive Intelligence of Primary School Children
    Anggra Frananda, Matteson Niva, Kailie Maharjan · 2024 · World Psychology
42. Pharmacogenomics-assisted schizophrenia management: A hybrid type 2 effectiveness-implementation study protocol to compare the clinical utility, cost-effectiveness, and barriers
    Aniruddha Basu, Atanu Kumar Dutta, Bhavani Shankara Bagepally, Saibal Das, Jerin Jose Cherian, Sudipto Roy, Pawan Kumar Maurya, Indranil Saha, Deepasree Sukumaran, Kumari Rina et al. · 2024 · PLoS ONE
43. Efficacy and safety of electroacupuncture on metabolic syndrome due to olanzapine and risperidone
    Yanzhe Ning, Hongxiao Jia, Pei Chen, Hong Zhu, Dongqing Yin · 2019 · Medicine
44. Management of Metabolic Syndrome in Schizophrenia
    Pragyan Sharma, Hannah E. Brown · 2020 · Psychiatric Annals
45. Clinical Use of Clozapine Serum Level and Management of Adverse Effects in an Adolescent with Difficult to Treat Schizophrenia
    Yasin Bez, Sindhura Kompella, Felicia Gallucci, A.W. Awerbuch, Barbara J. Coffey · 2021 · Journal of Child and Adolescent Psychopharmacology
46. GABAergic neuron dysregulation in a human neurodevelopmental model for major psychiatric disorders
    Ziyuan Guo, Yijing Su, Wei‐Kai Huang, Xiang Sean Yao, Yan Hong, Alice Gordin-Kivity, Ha Nam Nguyen, Zhexing Wen, Francisca Rojas, Chen Gong et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
47. Implantação e estruturação do serviço de farmácia clínica em um hospital psiquiátrico da rede pública de saúde
    Georgia C. COUTINHO, José R. ANDRADE-JÚNIOR, Mariana Dias Lula, Ronaldo Portela · 2021 · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
48. Development and Characterization of Transdermal Patch of Modified form of Brexpiperazol
    Dhaval P. Patel, Disha D. Suthar, Hetal Patel, Punit B. Parejiya · 2022 · Journal of Pharmaceutical Research International
49. Response Shift as a Possible Obstacle in Assessing Perceived Quality of Life and Burden of Care in Informal Caregivers of Individuals with Schizophrenia: A Narrative Review
    Jes Sebastian Denis Völker, I. Micluția, Adela-Melania Hanga · 2022 · Current Psychiatry Research and Reviews
50. Severity in schizophrenia patients receiving atypical antipsychotic medications
    Syed Meraj Fatmi · 2022 · Bioinformation
51. Diving with psychotropic medication: review of the literature and clinical considerations
    Praktijk Querido, Hilversum, the Netherlands, Abraham L Querido, Dutch Society of Diving and Hyperbaric Medicine, Bilthoven, the Netherlands, Chiel F Ebbelaar, Thijs T. Wingelaar, Dutch Society of Diving and Hyperbaric Medicine, Bilthoven, the Netherlands · 2023 · Diving and Hyperbaric Medicine Journal
52. Structural integrity of grey and white matter in schizophrenic patients by diffusion tensor imaging
    Aya Mohamed Reda Khalil, Heba Mohamed Samier, Mahmoud Abdelaziz Dawoud, Fatma Anas Elsharawy · 2023 · The Egyptian Journal of Radiology and Nuclear Medicine
53. Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study
    Tomohiko Kimura, Akifumi Kanai, Hiroyuki Muraoka, Yuichiro Takahashi, Masatomo Ara, Ken Inada · 2024 · Neuropsychopharmacology Reports
54. Deadly Aspiration Pneumonia Secondary to Superior Mesenteric Artery Syndrome
    Rhea Akel, Iskandar Daou, Dany Jamal, Elham Hobeika, Rany Aoun, Georges Nawfal · 2024 · Case Reports in Gastrointestinal Medicine
55. Prescribing Patterns of Psychotropic Medications for Common Psychiatric Disorders in a Mental Health Hospital in Tabuk
    Mostafa A. Sayed Ali, Palanisamy Amirthalingam, Vinoth Prabhu Veeramani, Abdulmajeed M Alasiri, Meshal N Alsalimi, Fahad O. Alatawi, Mutlaq M Albalawi · 2024 · Cureus
56. The Influence of Interpersonal Communication on Nomophobia in Married Couples
    Merry Dalimunthe, Annisa Lyona, Atikah Nuzuli Chari Negara, Ni’matuzahroh Ni’matuzahroh · 2024 · World Psychology
57. Peculiarities of personalized selection of antipsychotic drugs for schizophrenia treatment
    Olena O. Khaustova, Azize Asanova, Nataliia Dzeruzhynska, M.M. Matiash · 2024 · Medicni perspektivi
58. Management of psychosis with individualised homoeopathic medicines: A case series
    Karunakara Moorthi, Susu Pertin, Mohan Narvelil Devasia · 2024 · Indian Journal of Research in Homoeopathy
59. The relationship between self-reported antipsychotics side effects and depression in Saudi Arabia
    Yazed Alruthia · 2024 · Saudi Pharmaceutical Journal
60. Waist-height ratio highlights detrimental risk for olanzapine associated weight gain earlier than body mass index
    Ibrahim Mohammed Badamasi, Abiola Tajudeen, Shakirat D. Owolabi, Margaret Isioma Ojeahere, Asuku A. Yusuf, Mujittapha Umar Sirajo, Mustapha Ibrahim Gudaji · 2024 · International Journal of Adolescent Medicine and Health
61. Effects of continuous theta burst stimulation on patients with obsessive‒compulsive disorder (OCD): A systematic review and meta-analysis of randomized sham controlled trials
    Moiz Ul Haq Hashmi, Mahadev Khurana, Syeda Fizza Qadri, Fatima Kaleem Ahmed, Fatima Iqbal, Talat Mehmood, Wafa Farhan, Sahil Kumar, Akanksha Kumari · 2025 · Psychiatric Quarterly
62. Safety Profile of Antipsychotics as Predictors of the Quality of Life in Patients with Schizophrenia—An Inpatient Welfare Institution-Based Cross-Sectional Study
    Aleksandra D. Petrovic, Ana M. Barjaktarevic, Olivera Z. Kostic, Sara S. Mijailovic, Slobodan Јаnkovic, Marija V. Andjelkovic, Marijana Stanojević-Pirković, Katarina Parezanović-Ilić, Vladimir S. Janjic, Jana Desnica et al. · 2025 · Pharmaceuticals
63. An Exploration of Health Professionals' Views of Diet Intervention for Psychosis Management
    Kevin Williamson, John Anthony Baker, Nicola Clibbens · 2025 · International Journal of Mental Health Nursing
64. Schizophrenia, Nutrition and Choices in Kilojoules (SNaCK): protocol for a feasibility and acceptability randomised controlled trial of two dietary interventions
    D. J. G. Johnston, Urška Arnautovska, Andrea Baker, Ingrid J. Hickman, Hannah L. Mayr, Nicole Korman, Wolfgang Marx, Eryn Murray, Nicola Warren, Sarah Weighell et al. · 2025 · BJPsych Open
65. Genetic predisposition to unwanted side effects under antidepressants and antipsychotics: a molecular-genetic study of 902 patients over 6 weeks
    Hans H. Stassen, Silke Bachmann, René Bridler, Katja Cattapan, Annette M. Hartmann, Dan Rujescu, Erich Seifritz · 2025 · European Archives of Psychiatry and Clinical Neuroscience
66. Genetic inference of on-target and off-target side-effects of antipsychotic medications
    Andrew R. Elmore, Aws Sadik, Lavinia Paternoster, Golam Mohammed Khandaker, Tom R. Gaunt, Gibran Hemani · 2025 · PLoS Genetics
67. A Review of Support Staff Perception of and Training on Psychotropic Medication and Challenging Behavior in Adults With Intellectual and Developmental Disabilities
    Carissa Johnson, Claire Epperson, Odessa White, August Butterworth, Sarah Lowe, Grace L. Smith, Maria G. Valdovinos · 2025 · Behavioral Interventions
68. Quantifying the Tolerability of Antipsychotic Treatment-Related Side Effects in Schizophrenia: A Survey Study of Patients and Caregiver Proxies
    Melissa Culhane Maravić, Kelly Birch, Anh Thy H. Nguyen, Alicia Subasinghe, Elizabeth M. Stafford, Christopher Zacker · 2025 · Patient Preference and Adherence
69. Orthostatic Hypotension in Older Adults: A Narrative Review of Causes, Drug Impacts, and Management Strategies
    Vishal Bhati, Payal Mittal · 2025 · Current Hypertension Reviews
70. Clinical outcomes in first-episode schizophrenia: identifying predictors of relapse
    Mulualem Admasu Kelebie, Getasew Kibralew, Setegn Fentahun, Gidey Rtbey, Mekidem Aderaw, Wondale Endeshaw, Mitiku Belachew, Mulu Muche, Girum Nakie, Kindye Tesfaw et al. · 2025 · Social Psychiatry and Psychiatric Epidemiology
71. Interdisciplinary pharmaceutical care model engaging patient participation alleviate the anticholinergic burden in community-dwelling older adults: subgroup analysis of a randomized controlled trial
    Liyu Chen, Ling‐Chiao Liao, Chin‐Ju Chuang, Cheng‐Ying Hsieh, Yung‐Cheng Huang, Yi‐Hsuan Yang, Wan‐Ting Chang, Shau‐Huai Fu, Feng-Jung Yang, Kai‐Chieh Chang et al. · 2025 · Therapeutic Advances in Drug Safety
72. Determinants of changes in self-esteem after remission of first-episode psychosis: A study of associated cross-sectional and longitudinal factors
    Marit Hidding, Elisabeth C. D. van der Stouwe, Bram‐Sieben Rosema, Marieke Begemann, Lieuwe de Haan, Jim van Os, Sanne Koops, Ben F. M. Wijnen, Nynke Boonstra, Wim Veling · 2025 · Psychological Medicine
73. Double‐Duty Drugs: Repositioning Antipsychotics to Combat Bacterial Infections
    Navid Faraji, Mohammad Abavisani, Negar Ebadpour, Sercan Karav, Prashant Kesharwani, Amirhossein Sahebkar · 2026 · CNS Neuroscience & Therapeutics
74. Lived experiences of shared decision-making in young adults prescribed antipsychotics: a qualitative interview study
    Holly Grey, Laura Lindsey · 2026 · International Journal of Clinical Pharmacy
75. Application of artificial intelligence in schizophrenia rehabilitation management: a systematic scoping review
    Hongyi Yang, Fangyuan Chang, Fumie Muroi, Zhao Liu, Weibo Zhang, Jun Cai · 2026 · Translational Psychiatry
76. Exploring Colombian medicinal flora used in indigenous and campesino health systems for neuropsychiatric disorders and neuropharmacological potential: an ethnopharmacological review
    Katrin Brache, Mauricio Diazgranados · 2026 · Frontiers in Pharmacology
77. Second-Generation Antipsychotics for Depression in Serious Illness: A First-Line Augmentation Strategy
    Gregg Alan Robbins-Welty, Mia Pattillo, Danielle Chammas, Karolina Sadowska, Cara L. McDermott, Nneka N. Ufere, Jason A. Webb, Daniel Shalev · 2026 · Journal of Pain and Symptom Management
78. Understanding Psychotic Depression
    Michel Bourin · 2026 · Advances in experimental medicine and biology
79. Real-world use of brexpiprazole during inpatient treatment for schizophrenia: continuation, discontinuation, and concomitant psychotropics
    Yuki Noriyama, S Araki, Ryohei Takada, Hiroaki Fukui, Yuya Honda, Kazuki Okumura, Yuki Nishi, Minobu Ikehara, Takashi Okada · 2026 · Frontiers in Psychiatry
80. Credentialed art therapy as a non-pharmacological intervention for neuropsychiatric symptoms reduction in persons living with dementia-a systematic review and meta-analysis
    Elena Guseva, Isabelle Vedel, Geneviève Gore, Ovidiu Lungu, Zahinoor Ismail, Walter Wittich, Machelle Wilchesky · 2026 · International Psychogeriatrics
81. Light exposure at night and subjective and objective sleep parameters in patients with schizophrenia: A cross-sectional analysis of the LENS study
    Ryota Miyake, Yuichi Esaki, Rina Taniguchi, Kenji Obayashi, Keigo Saeki, Soji Tsuboi, Kiyoshi Fujita, Nakao Iwata, Tsuyoshi Kitajima · 2026 · Psychiatry Research
82. Acute Laryngeal Dystonia Mimicking Anaphylaxis Following Antipsychotic Initiation: A Case Report
    Devina Wadhwa · 2026 · Case Reports in Psychiatry
83. Not all antipsychotic polypharmacy is the same
    Norio Yasui‐Furukori · 2026 · International Clinical Psychopharmacology
84. The role of PRKRA mutation in antipsychotic-induced extrapyramidal symptoms: a case report and implications for precision psychiatry
    Mude Jeevan Naik, Simran Arora, Likhita Thippeswamy, Deepak Shantaram Ghadigaonkar, Satish Suhas, Guru S. Gowda, V Senthil K. Reddy, John P. John, Sanjeev Jain · 2026 · Psychiatric Genetics
85. Changes in Weight and Metabolic Indices after Switching to Aripiprazole Once-Monthly in Patients with Schizophrenia According to Prior Oral Antipsychotics
    Seoyoung Kim, Kyu Young Lee, Hyun Seung Chee, Joonho Choi, Young-Hoon Kim, Won‐Hyoung Kim, Heon-Jeong Lee, Ji-Woon Jeong, Yu Sang Lee, Il Ho Park et al. · 2026 · Pharmacopsychiatry
86. Aphagia in frontal lobe syndrome following traumatic brain injury
    Fatimah Binti Ahmedy, Jiann Lin Loo, Mazlina Mazlan · 2020 · Indian Journal of Psychiatry
87. Atypical Antipsychotic Effect On Bone Mineral Density
    Wisam Al Jumaili, Shailesh Bobby Jain · 2021 · StatPearls
88. Let's talk about the negative experiences of Black mental health service users in England: Now is the moment to consider watchful waiting to support their recovery
    Isaac Tuffour · 2021 · Nursing Inquiry
89. Beneficial Effects of Acupuncture as a Complementary Treatment for Patients Receiving Paroxetine For Major Depressive Disorder: A Meta-Analysis
    Minh Duc Nguyen, Quoc Vinh Nguyen, Cay Doan Ha, Thanh Van Tran, Linh Vu Phuong Dang · 2021 · Medical Acupuncture
90. Are TOPF and WRAT WR Interchangeable Measures among Psychiatric Inpatients?
    Alexis S. Rosen, Loren C. King, Dominique I. Kinney, Stephen R. Nitch, David M. Glassmire · 2021 · Archives of Clinical Neuropsychology
91. Acute Dystonia With Rhabdomyolysis Induced by Paliperidone Palmitate: A Rare Adverse Effect
    Nishant Allena, Sai Krishnaraya Doppalapudi, Sneha Khanal, Steven Tank, Rabih Nasr · 2022 · Cureus
92. Fasting while on antipsychotics: an exploration of the decision-making process of Muslim patients during Ramadan
    Zeinab El Dirani, Lynn Adam, Mohamad El-Hashash, Fadel Shihimi, Joseph El‐Khoury · 2022 · Mental Health Religion & Culture
93. Pharmacotherapy in Prader-Willi Syndrome
    Janice L. Forster · 2022 · Springer eBooks
94. Differential Treatment Responses in Pakistani Schizophrenia Samples: Correlation with Sociodemographic Parameters, Drug Addiction, Attitude to the Treatment and Antipsychotic Agents
    Umme Habiba, Aafia Malik, Ghazala Kaukab Raja, Muhammad Raza Memon, Asad Tamizuddin Nizami, Rafaqat Ishaq, Muhammad Ilyas, Hadi Valadi, Muhammad Nawaz, Pakeeza Arzoo Shaiq · 2023 · Brain Sciences
95. Mapping Drug-gene Interactions to Identify Potential Drug Candidates Targeting Envelope Protein in SARS-CoV-2 Infection
    Byapti Ghosh, Troyee Das, Gourab Das, Nilkanta Chowdhury, Angshuman Bagchi, Zhumur Ghosh · 2023 · Current Bioinformatics
96. A Medication Assessment Tool to Evaluate Prescribers’ Adherence to Practice Guidelines in Acute-Phase Schizophrenia Treatment: Development and Psychometric properties
    Atefeh Akbari, Hamid Sharif Nia, Mehran Zarghami, Paria Azari, Fatemeh Hendouei, Narjes Hendouei · 2023 · Iranian Journal of Psychiatry and Behavioral Sciences
97. Analysis of Atypical Antipsychotics-Induced Adverse Events Related to Diabetes Mellitus in Patients With Dementia Using the Japanese Adverse Drug Event Report Database
    Habuchi Fuga, Natsuko Ishida, Ryo Matsushita, Junko Ishizaki, Yukio Suga · 2023 · Annals of Pharmacotherapy
98. Pharmacist-led medicines optimisation service in an inpatient mental health setting
    Caroline Hynes-Ryan, Aoife Carolan, Larkin Feeney, Judith Strawbridge, Audrey Purcell, Georgina Gilsenan, Darragh O’Donoghue, Dolores Keating · 2023 · Irish Journal of Psychological Medicine
99. Effect of Cuscuta epithymum Acquainted with Risperidone on the Improvement of Clinical Symptoms and Cognitive Impairment in Patients with Schizophrenia: A Triple-Blind Randomized Placebo-Controlled Trial
    Maedeh Parvizi, Farbod Fadai, Moahammad Reza Khodaei-Ardakani, Gholamreza Amin, Leila Abdi, Mehdi Noroozi, Iman Ansari · 2019 · Galen Medical Journal
100. Neuroleptic malignant syndrome: a neuro-psychiatric emergency
     Janet Curtis, Brian Sengstock · 2024 · Journal of Paramedic Practice